BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1143260)

  • 21. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
    Bauer HW; Schmiedt E
    Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
    Bruce AW; Mahan DE; Belville WD
    Urol Clin North Am; 1980 Oct; 7(3):645-52. PubMed ID: 7456177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoreactive prostate-specific acid phosphatase in prostatic cancer.
    Kontturi M; Vihko P; Lukkarinen O; Vihko R
    Scand J Clin Lab Invest Suppl; 1985; 179():67-74. PubMed ID: 3866311
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of 2 methods of determining prostatic acid phosphatase].
    Venturini M; Calafati P; De Grandi R; Pescatore D; Varaldo M; Natta G
    Arch Maragliano Patol Clin; 1980; 36():35-41. PubMed ID: 6178374
    [No Abstract]   [Full Text] [Related]  

  • 25. The radioimmunochemical measurement of prostatic acid phosphatase: current state of the art.
    Cooper JF
    Urol Clin North Am; 1980 Oct; 7(3):653-65. PubMed ID: 6161460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in acid phosphatase levels during various prostatic operations].
    Vitsou-Georgallis H; Goulandris N; Marketos N; Dimopoulos C
    Acta Urol Belg; 1980 Oct; 48(4):488-97. PubMed ID: 6161530
    [No Abstract]   [Full Text] [Related]  

  • 27. [The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)].
    Tellier JL; Chatal JF; Bourdin S; Auvigne J; Etienne P; Faye R
    J Urol (Paris); 1981; 87(3):169-73. PubMed ID: 7240777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Planning and evaluation of diagnostic tests: failure of S-prostatic acid phosphatase in screening for early-stage prostatic carcinoma.
    Gerhardt W
    Scand J Clin Lab Invest Suppl; 1985; 179():31-41. PubMed ID: 3866307
    [No Abstract]   [Full Text] [Related]  

  • 29. Isoenzymes of alkaline phosphatase in serum of patients with prostatic cancer.
    Røhl H; Jørgensen PJ; Hørder M
    Scand J Clin Lab Invest Suppl; 1985; 179():101-5. PubMed ID: 3866302
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
    Canal P; Soula G
    Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Activity of phosphatase in the blood serum in prostatic carcinoma depending on the stage of the tumor].
    Wehnert J; Meissner D
    Z Urol Nephrol; 1976 Apr; 69(4):243-50. PubMed ID: 952097
    [No Abstract]   [Full Text] [Related]  

  • 32. Carcinoma of the prostate presenting as obstructive carcinoma of the rectum.
    Mir M; Dikranian H; Cogbill CL
    Am Surg; 1973 Oct; 39(10):582-6. PubMed ID: 4728151
    [No Abstract]   [Full Text] [Related]  

  • 33. [New prospective diagnostic serum markers in prostatic cancer].
    Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
    Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer].
    Bauer HW
    Med Welt; 1982 Nov; 33(46):1616-21. PubMed ID: 6185820
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serum acid phosphatase determined by the radioimmunochemical method (P.A.P.-RIA): its diagnostic value in prostatic cancer].
    Marczyńska A; Kulpa J; Adamczyk B; Leńko J
    Przegl Lek; 1982 Sep; 39(8):573-6. PubMed ID: 6182582
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum prostatic acid phosphatase activity and prostate specific antigen when the prostate gland is enlarged.
    Jenkins D; Jones RT; Clarke AM
    Med Lab Sci; 1991 Apr; 48(2):161-3. PubMed ID: 1719330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Semeiological value of so-called prostatic tartrate-labile acid phosphatases. (Critical study of 500 medical records)].
    von Niederhäusern W; Tuchschmid D
    Ann Urol (Paris); 1970 Sep; 4(3):205-11. PubMed ID: 5472678
    [No Abstract]   [Full Text] [Related]  

  • 38. [Early diagnosis of metastases in prostatic carcinoma].
    Rutishauser G
    Dtsch Med Wochenschr; 1972 Sep; 97(35):1304-5. PubMed ID: 5050244
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acid phosphatase--interpretation of the test results].
    Ishibe T
    Nihon Rinsho; 1973; 31():1822-31. PubMed ID: 4582282
    [No Abstract]   [Full Text] [Related]  

  • 40. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
    Hamami G
    Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.